Table 10 Availability of surveyed high-end antibiotics at secondary care and tertiary care public facilities and at private sector facilities
From: Access to antibiotics in New Delhi, India: implications for antibiotic policy
Antibiotic name | Public sector (n = 15) | Retail pharmacies | Chain pharmacies |
|---|---|---|---|
(n = 40) | (n = 40) | ||
Cefepime 1 g Inj | 20.0% | 0.0% | 10.0% |
Ceftazidime 1 g vial | 73.3% | 5.0% | 20.0% |
Colistin 1000000units/vial | 0.0% | 0.0% | 2.5% |
Gemifloxacin 320 mg tab/cap | 0.0% | 37.5% | 50.0% |
Imipenem + cilastin500mg + 500 mg Inj | 13.3% | 0.0% | 22.5% |
Meropenem 500 mg Inj | 60.0% | 32.5% | 52.5% |
Moxifloxacin 400 mg tab/cap | 0.0% | 40.0% | 72.5% |
Vancomycin 500 mg inj | 53.3% | 5.0% | 7.5% |